This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, The University of Erlangen, Ulm University. Active years: 2002-2021.
Location History:
- Erlangen, DE (2002)
- Ulm, DE (2012 - 2021)
Company Filing History:
1 out of 5,383 
1 out of 2 
1 out of 1 
Years Active: 2002-2021
Title: The Innovations of Inventor Steffen Stenger
Introduction: Steffen Stenger, an accomplished inventor based in Ulm, Germany, has made significant contributions to the field of biomedical research. With a total of three patents to his name, his work primarily focuses on advancements in immunology, particularly relating to polycytotoxic T cells.
Latest Patents: Among his latest innovations is a patent related to compositions and methods concerning polycytotoxic T cells. This invention encompasses various aspects including the development of compositions that comprise these cells, methods for their administration, and techniques for monitoring immune responses in subjects. Specifically, it outlines processes for determining the concentration of polycytotoxic T cells in the blood, which can be vital in treating conditions or diseases through targeted antibody therapies. Additionally, another patent of his relates to compounds aimed at the treatment or prophylaxis of tuberculosis, showcasing his versatility as an inventor.
Career Highlights: Steffen Stenger has worked with prominent institutions, including the University of California, signifying his robust academic background and dedication to research. His innovative spirit has led him to explore critical areas of medicine and immunotherapy, resulting in breakthroughs that could enhance therapeutic approaches.
Collaborations: Throughout his career, Stenger has collaborated with distinguished individuals such as Robert L. Modlin and Dennis Alan Hanson. These collaborations have likely fostered an environment of innovation and creativity, enabling fruitful research endeavors and the successful fruition of his patents.
Conclusion: Steffen Stenger's contributions to the field of immunology through his patent portfolio exemplify his role as an influential inventor. His recent work on polycytotoxic T cells and tuberculosis treatment underscores the importance of continued innovation in healthcare. As research progresses, Stenger's inventions may hold the potential to improve therapeutic strategies for various diseases.